Thymulin (Serum Thymic Factor) Research Peptide

What Is Thymulin?

Thymulin is a nine-amino-acid peptide hormone made by the epithelial cells of the thymus, the organ where T cells mature. Its sequence begins with pyroglutamic acid (pGlu), a ring-closed residue that protects the peptide’s N-terminus. It is often confused with the thymosins, such as thymosin alpha-1, but it is a different peptide with a different sequence and function.

What sets thymulin apart is its dependence on zinc. The peptide binds one zinc ion per molecule, and only this zinc-bound form adopts the three-dimensional shape needed for biological activity. Without zinc it is an inactive apopeptide. Thymic epithelial cells contain both zinc and the peptide, which suggests thymulin is released already in its active, zinc-bound form. That zinc switch has made thymulin a standard research tool for studying how zinc status affects immune signaling.

Thymulin has been studied mainly in the context of T-cell differentiation, thymic function and immune aging. As the thymus shrinks with age, a process called thymic involution, circulating thymulin declines with it. Researchers have also examined its links to the endocrine system, since it interacts with pathways involving pituitary hormones. For related research compounds, see peptides for longevity research.

This product is strictly for research purposes only. Not approved for human or animal use.

Key Characteristics

Molecular Profile

Physical Properties

Thymulin in Published Research

Much of the foundational thymulin research came from Mireille Dardenne, Jean-François Bach and colleagues. Their work showed that the peptide binds zinc in an equal ratio, that the zinc-bound form has a distinct three-dimensional structure, and that even mild zinc deficiency lowers serum thymulin activity in animal models and in people. Activity was restored when zinc was added back, both in the body and in lab samples, which led researchers to propose serum thymulin as a sensitive marker of zinc status.

Early studies also examined thymulin’s role in T-cell differentiation inside and outside the thymus, and its ability to restore thymus-dependent immune responses in thymus-deficient and stressed animal models. Later preclinical work explored thymulin in models of inflammation, pain signaling and lung disease.

Most of the evidence comes from animal and cell studies rather than large human trials, and thymulin has never been developed into an approved drug. Every lot is verified by HPLC and mass spectrometry; see how to read a peptide COA and peptide purity vs net peptide content.

Frequently Asked Questions

What is Thymulin studied for in research?

Thymulin is studied mainly for its role in T-cell differentiation, thymic function and immune aging, and as a model for how zinc status affects immune signaling.

Why does Thymulin need zinc?

Zinc binds the peptide in a 1:1 ratio and locks it into its active shape. Without zinc, thymulin is reported to have no immunological activity in research models.

Is Thymulin the same as Thymosin?

No. Thymulin and the thymosins, such as thymosin alpha-1 and thymosin beta-4, are different peptides with different sequences. They are often confused because all are linked to the thymus.

What have studies found about Thymulin?

Preclinical studies link zinc-bound thymulin to T-cell maturation in zinc-deficient and thymus-depleted animal models, and to communication between the immune and endocrine systems. These are research observations, not established clinical effects.

Is Thymulin FDA approved?

No. Thymulin has never been developed into an approved drug. This product is for laboratory research only.

How should Thymulin be stored?

Refrigerated at 2–8 °C (36–46 °F), sealed, dry and away from light. For long-term storage, −20 °C. Each 10 mg kit contains 10 vials. Here’s why freeze-dried peptides ship safely at room temperature.